An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making

OBJECTIVES: The objective of this study was to determine the nature of evidence used to support the withdrawal of marketing authorisations of drug products for safety reasons throughout the European Union (EU) between 2002 and 2011. SETTING: Products withdrawn, either by a medicines agency or a mark...

Descripción completa

Detalles Bibliográficos
Autores principales: McNaughton, Rhian, Huet, Gwenaël, Shakir, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902466/
https://www.ncbi.nlm.nih.gov/pubmed/24435895
http://dx.doi.org/10.1136/bmjopen-2013-004221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902466/
https://www.ncbi.nlm.nih.gov/pubmed/24435895
http://dx.doi.org/10.1136/bmjopen-2013-004221

Ejemplares similares